Project Grant R56EB036545
Award Date 8/8/25
Completion Date 7/31/26
Dollars Obligated $617K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- This $1,169,317 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a molecular toolbox for non-invasive methods to kill cells in situ via specific cell death pathways using safe, tunable temperature stimuli. The objective is to generate single protein constructs that can trigger apoptosis, necroptosis, or pyroptosis...
- This $438,900 Project Grant was awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant funds research to develop a "three-cell (T-NK-macrophage) immunotherapy system" using chimeric antigen receptor (CAR) and synthetic cytokine receptor (SCR) technologies. The primary goal is to engineer the three immune cell types to function...
- This Project Grant award of $621,158 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program, supports research to create a "human macrophage design toolkit" for engineering therapeutic macrophages. The goal is to elucidate the biological and gene circuit design principles needed to engineer macrophages that can suppress inflammatory...
- This $406,250 Project Grant was awarded on August 1, 2025 by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The project aims to develop novel computational methods that can accurately characterize the reorganization of water structure and its impact on the thermodynamics and kinetics of protein interactions. This will be applied to three specific projects: (1) interactions between reader proteins and...
- This federal Project Grant award, valued at $231,934.00, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant supports the development of a new modular platform technology that mimics lymph nodes to improve the engineering of T cells for cellular immunotherapy. The funded research aims to create biomimetic scaffolds that can...
- The University of Pennsylvania received a $446,875 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award will support research to develop deep learning tools that can predict patient risk, generate synthetic clinical biomarkers, and provide normative data from multimodal and longitudinal health data related to metabolic...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $222,708 Project Grant to The Trustees of Columbia University in the City of New York under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant, which runs from May 1, 2025 to December 31, 2028, will support research to develop self-assembling modular hydrogels that can programmably display glycan ligands to direct immune cell phenotypes. This...
- The University of Michigan received a $1,714,839 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The objective of this proof-of-concept study is to develop bispecific antibodies (Babs) fused to IL-2, referred to as IL-2 immunocytokines, that can be delivered non-invasively via intravenous administration, efficiently cross the...
- The University of Pennsylvania has been awarded a $1,648,086 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855). The 5-year grant, commencing on May 13, 2025 and concluding on April 30, 2030, supports research to develop immune tolerance strategies for kidney transplant recipients. The research aims to induce B-cell and T-cell unresponsiveness through the use of...
- This federal Project Grant award of $446,875.00, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research to decipher novel cell death mechanisms and metabolic reprogramming in response to microenvironmental stress. The primary awardee, The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, will leverage their expertise in...
This $616,897 Project Grant was awarded on August 8, 2025 by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant supports the development of synthetic compartments that can insulate and sequester signaling components to rewire inflammatory signaling and restore immune cell function. Key objectives include insulating and shutting down components of the JAK-STAT signaling pathway in the type I interferon pathway to prevent T cell exhaustion. The research is being conducted by the University of Pennsylvania, a prominent private research university and academic medical center in Philadelphia.
Generated 10/21/25, 6:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $616.9k | 8/12/25 |